- Abbott said the Michigan facility could reopen in two weeks if FDA approved.
- But even in that case, it takes six to eight weeks for the formula to get to the shelves.
- Meanwhile, the FDA is busy working to address the national milk formula shortage.
Abbott, a company that makes milk powder, said it could do so in two weeks if the FDA approves the reopening of its Michigan facility. It will still take months for the milk powder to appear on the shelves.
The company recalled several lots of its Similac, Alimentum and EleCare formula brands in February after complaints that infants were infected with the environmental bacterium Chronobacter sakazaki. All four babies used formula produced at the company’s Sturges, Michigan plant.
The recall got worse Nationwide shortage of infant formula.
Despite Abbott’s timeline, Washington Post FDA reported that an investigation into the facility had not yet been completed.
that much FDA report He said cronobacter sakazakii bacteria were found in several places within the facility and other safety precautions, such as wearing gloves, were not followed.
“Factories remain closed as companies work to rectify findings related to processes, procedures and conditions. FDA Observation An FDA spokeswoman told the Post during an inspection of the facility, which raised concerns that powdered infant formula produced at the facility before the FDA’s inspection was at risk of contamination.
Meanwhile, as more than 40% of the main powdered milk is sold out, the FDA said All official U.S.-based manufacturers have increased production in recent weeks, and more will be available soon.
Abbott also said that products are being shipped from Ireland’s Cootehill facility to offer “the state’s special supplemental nutrition program for women, infants and children (WIC) consumers”.
Also, to ease the burden on parents, Post said Califf plans to allow the FDA to allow foreign manufacturers and suppliers to ship products to the United States.
— Dr. Robert M. Caliph (@DrCaliff_FDA) May 13, 2022
“FDA is working closely with our federal partners to safely get as many infant formula as possible to US shelves as quickly as possible. This is FDA’s top priority. Our team will continue to work around the clock to address current supply issues as quickly as possible. FDA Commissioner Robert Califf said, “As far as possible Twitter.